RECENT ACHIEVEMENTS IN MOLECULAR DIAGNOSIS OF THE BREAST CARCINOMA

Authors

  • V. FULGA
  • O. MAZURU
  • V. DAVID
  • L. RUDICO
  • V. MAZURU
  • L. SAPTEFRATI

Abstract

Implementation of screening methods led to considerable improvement in early diagnosis, and as a result in mortality of breast cancer. But in spite of that malignant affection of this organ still remains one of the most frequent all over the world. This phenomenon could be partially explained by the lack of description in detail of biological heterogeneity of the mammary carcinomas that would take in consideration such aspects like molecular alterations, cellular content and the sensibility towards the treatment.

Downloads

Issue

No. 217 (2015): Частина 1 (англ)

Section

Article

License

Relationship between right holders and users shall be governed by the terms of the license Creative Commons  Attribution – non-commercial – Distribution On Same Conditions 4.0 international (CC BY-NC-SA 4.0):https://creativecommons.org/licenses/by-nc-sa/4.0/deed.uk

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).